Natera

Associate Medical Director

Remote

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Medical Devices, DiagnosticsIndustries

Position Overview

  • Location Type: Remote
  • Employment Type: Full-time
  • Salary: Not specified

The Associate Medical Director is a critical leadership role that dictates Natera’s success by influencing usage and confidence in molecular diagnostics into routine medical practice. This will initially be an individual contributor role with an opportunity to build a team as the business grows.

Primary Responsibilities

  • Work with the Medical Director, Oncology on the clinical development of molecular diagnostic tools in the fields of heart transplant and heart failure.
  • Lead design and implementation of new treatment protocols that incorporate Natera’s transplant-focused diagnostic products.
  • Recruit industry-leading PIs and clinical sites to participate in clinical studies, meeting budget and timeline requirements in collaboration with Clinical Trial Operations dept.
  • Advise on product development for our testing portfolio: identify clinical unmet needs, new product opportunities, critical product features, product intended use, design and content of test reports, minimum validation studies.
  • Medical Affairs post-launch: clinical interpretation of test results, customer support for physicians, advise on pre-and post-test counseling for patients.
  • Drive medical education efforts to support successful launch and commercialization of our transplant product portfolio by teaching the community how to use the tests.
  • Recruit key opinion leaders (KOLs) for medical advisory board, participate as a leader in advisory meetings.
  • Support the publication strategy by crafting papers in collaboration with Scientific Communications dept.
  • Provide medical input into regulatory submissions.
  • Represent Natera’s medical voice in any public relations related to Oncology.
  • This role works with PHI on a regular basis both in paper and electronic form and have access to various technologies to access PHI (paper and electronic) in order to perform the job.
  • Employee must complete training relating to HIPAA/PHI privacy, General Policies and Procedure Compliance training and security training as soon as possible but not later than the first 30 days of hire.
  • Must maintain a current status on Natera training requirements.

Qualifications

  • M.D. and/or Ph.D. required
  • At least 5 years of practice experience (post fellowship) in GI Oncology, seeing and treating patients.
  • Knowledge and facility with practice guidelines across different GI cancer types.
  • At least 3 years of clinical trial experience in academia, biotech industry, or equivalent.
  • At least 2 years’ experience in industry, Medical Affairs, or Clinical Development with record of success in commercializing transplant products (therapeutics or diagnostics) preferred.
  • Willing to travel >40% of the time (focus on S

Application Instructions

  • Not specified.

Skills

Molecular diagnostics
Clinical development
Protocol design
Clinical trial recruitment
Product development
Test interpretation
Customer support
Medical education
KOL engagement
Publication strategy
Regulatory input
Public relations

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI